Cargando…
Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Published by Elsevier Ltd on behalf of The British Infection Association.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151458/ https://www.ncbi.nlm.nih.gov/pubmed/35659914 http://dx.doi.org/10.1016/j.jinf.2022.05.030 |
| _version_ | 1784717487013625856 |
|---|---|
| author | Wang, Bin Fu, Jiantao Lu, Anqian Yang, Jin |
| author_facet | Wang, Bin Fu, Jiantao Lu, Anqian Yang, Jin |
| author_sort | Wang, Bin |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9151458 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Published by Elsevier Ltd on behalf of The British Infection Association. |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-91514582022-05-31 Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer Wang, Bin Fu, Jiantao Lu, Anqian Yang, Jin J Infect Letter to the Editor Published by Elsevier Ltd on behalf of The British Infection Association. 2022-09 2022-05-31 /pmc/articles/PMC9151458/ /pubmed/35659914 http://dx.doi.org/10.1016/j.jinf.2022.05.030 Text en © 2022 Published by Elsevier Ltd on behalf of The British Infection Association. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
| spellingShingle | Letter to the Editor Wang, Bin Fu, Jiantao Lu, Anqian Yang, Jin Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer |
| title | Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer |
| title_full | Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer |
| title_fullStr | Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer |
| title_full_unstemmed | Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer |
| title_short | Suitability assessment of CD24 targeted-therapy in the cancer patients with COVID-19: Preliminary results from pan-cancer |
| title_sort | suitability assessment of cd24 targeted-therapy in the cancer patients with covid-19: preliminary results from pan-cancer |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151458/ https://www.ncbi.nlm.nih.gov/pubmed/35659914 http://dx.doi.org/10.1016/j.jinf.2022.05.030 |
| work_keys_str_mv | AT wangbin suitabilityassessmentofcd24targetedtherapyinthecancerpatientswithcovid19preliminaryresultsfrompancancer AT fujiantao suitabilityassessmentofcd24targetedtherapyinthecancerpatientswithcovid19preliminaryresultsfrompancancer AT luanqian suitabilityassessmentofcd24targetedtherapyinthecancerpatientswithcovid19preliminaryresultsfrompancancer AT yangjin suitabilityassessmentofcd24targetedtherapyinthecancerpatientswithcovid19preliminaryresultsfrompancancer |